Tripeptide Aggregation Prediction via Hydrophilicity Adjustment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for predicting the self-assembly behavior of short peptides, such as tripeptides, are limited by the need for serendipitous discovery and lack of amphiphilicity, which restricts their aqueous solubility and applications, and existing virtual screening techniques are not practical for screening all possible tripeptide combinations for aggregation propensity.

Innovation Solution

Development of an improved virtual screening method that uses a hydrophilicity-adjusted measure of aggregation propensity (APH) to identify tripeptides with high aggregation potential, allowing for the selection of peptides that form aggregates and potentially gelate, and the method can account for pH effects on peptide aggregation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional aggregation propensity measures are used to screen tripeptides, then hydrophobic sequences can be identified that form aggregates, but the peptides lack amphiphilicity required for gelation and have limited aqueous solubility

Engineering Contradiction:
Improveaggregation prediction accuracyVSAvoidpeptide amphiphilicity and gelation capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent modifies the aggregation propensity calculation by introducing a hydrophilicity adjustment factor. The APH score is calculated as APH = AP × (1 - logP), where AP is the original aggregation propensity and logP represents hydrophilicity. This parameter change transforms the screening criterion to simultaneously favor both aggregation-prone and sufficiently hydrophilic sequences, resolving the contradiction between aggregation ability and amphiphilicity requirements for gelation.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If all 8000 tripeptide combinations are synthesized and tested experimentally to screen for aggregation propensity, then comprehensive data can be obtained, but the process is impractical due to time and resource constraints

Engineering Contradiction:
Improveaggregation propensity data completenessVSAvoidscreening efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent employs computational modeling to create virtual copies of all 8000 tripeptide sequences. Instead of synthesizing and testing each peptide experimentally, the aggregation propensity is calculated in silico using the APH metric. This copying approach allows comprehensive screening of the entire tripeptide space without the time and resource costs of experimental synthesis, dramatically improving productivity while maintaining measurement precision through systematic computational evaluation.

Inventive Principle:
Principle #26Copying

3Reliability

If hydrophobic tripeptides are selected based on high aggregation propensity, then aggregates can be formed, but the peptides have poor aqueous solubility and limited biological applications

Engineering Contradiction:
Improveaggregate formation capabilityVSAvoidaqueous solubility
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent changes the selection parameter from pure aggregation propensity (AP) to hydrophilicity-adjusted aggregation propensity (APH). By incorporating the logP term that represents hydrophilicity, the screening criterion is modified to APH = AP × (1 - logP). This ensures that only peptides with sufficient hydrophilicity are selected, even if they have high aggregation propensity. The result is peptides that can form aggregates while maintaining adequate aqueous solubility for biological applications.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the identification of tripeptides with high aggregation propensity, including those that form hydrogels, and demonstrates the ability to predict self-assembly behaviors, expanding the scope of peptide applications in biological, medical, and nanotechnology fields.

Implementation Method 1

Peptides with the ability to spontaneously assemble into nanostructures of defined size, shape and chemical functionality

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

largely limited to hydrophobic sequences, which form (nanoscale) aggregates

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 3

adjusting a measure of propensity of aggregation (AP) for the peptide in dependence on a measure of hydrophilicity for the peptide

Methodology Applied
Scientific EffectHydrophobicity-hydrophilicity balance: Amphiphiles

Implementation Method 4

The screening method may be expanded to take account of how other parameters, such a pH, may affect peptide aggregation

Methodology Applied
Scientific EffectpH-responsive aggregation: Ionisation

Data Source

PatentEP3204402B1Self-assembling tripeptides
Publication Date: 2022.02.16 ENDO BIOLOGICS INC
  • EP3204402B1 patent drawingFigure 1a~1b
  • EP3204402B1 patent drawingFigure 2a
  • EP3204402B1 patent drawingFigure 2b

AI summary

The present invention relates to a method of predicting the propensity of tripeptides to from aggregates in solution. The present invention also provides tripeptides which are able to form aggregates in solution, as well as uses thereof. The present invention also provides nanostructures formed by self-aggregation of tripeptides of the present invention. The present invention also provides pH responsive aggregates as well as methods of screening for the ability of a tripeptide to form a pH dependent aggregate or gel.